Director/PDMR Shareholding

MGC Pharmaceuticals Limited

11 January 2024

 

MGC Pharmaceuticals Ltd.

PDMR Notification

11 January 2024

ASX, LSE: MXC

MGC Pharmaceuticals Ltd ('MGC Pharma' or 'the Company') wishes to advise that the following Persons Discharging Managerial Responsibilities (PDMR) have dealt with shares in MGC Pharma, and this notification is made in accordance the UK Market Abuse Regulations.

The shares subject of this notice were issued to the PDMR's as part of their working contracts and as consideration for services rendered in lieu of cash payments

1	Details of the person discharging managerial responsibilities/person closely associated
(a)	Name		Amir Polak
2	Reason for the notification
(a)	Position		Chief Pharmaceutical Development Officer
(b)	Initial notification/amendment		Initial
(c)	If amendment: reason		n/a
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
	Full name of entity		MGC Pharmaceuticals Limited
	Legal Entity Identifier Code		213800HRE3FQJ6RK4H10
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
(a)	Description of the financial instrument, type of instrument		Fully Paid Ordinary Shares
(b)	Identification Code (ISIN)		AU000000MXC6
(c)	Nature of transaction		Shares issued as part of their working contracts and as consideration for services rendered in lieu of cash payments
(d)	Currency	Price		Volume	Total
	AUD	A$0.55		600,000	A$330,000
	Aggregated information
	AUD	A$0.55		600,000	A$330,000
(e)	Date of transaction		10 January 2024
(f)	Place of transaction		Outside a trading venue

1	Details of the person discharging managerial responsibilities/person closely associated
(a)	Name		Sabina Suljakovic
2	Reason for the notification
(a)	Position		Vice President of Global Quality
(b)	Initial notification/amendment		Initial
(c)	If amendment: reason		n/a
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
	Full name of entity		MGC Pharmaceuticals Limited
	Legal Entity Identifier Code		213800HRE3FQJ6RK4H10
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
(a)	Description of the financial instrument, type of instrument		Fully Paid Ordinary Shares
(b)	Identification Code (ISIN)		AU000000MXC6
(c)	Nature of transaction		Shares issued as part of their working contracts and as consideration for services rendered in lieu of cash payments
(d)	Currency	Price		Volume	Total
	AUD	A$0.55		17,000	A$9,350
	Aggregated information
	AUD	A$0.55		17,000	A$9,350
(e)	Date of transaction		10 January 2024
(f)	Place of transaction		Outside a trading venue

1	Details of the person discharging managerial responsibilities/person closely associated
(a)	Name		Yair Tal
2	Reason for the notification
(a)	Position		Chief Information Security Officer
(b)	Initial notification/amendment		Initial
(c)	If amendment: reason		n/a
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
	Full name of entity		MGC Pharmaceuticals Limited
	Legal Entity Identifier Code		213800HRE3FQJ6RK4H10
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
(a)	Description of the financial instrument, type of instrument		Fully Paid Ordinary Shares
(b)	Identification Code (ISIN)		AU000000MXC6
(c)	Nature of transaction		Shares issued as part of their working contracts and as consideration for services rendered in lieu of cash payments
(d)	Currency	Price		Volume	Total
	AUD	A$0.55		300,000	A$165,000
	Aggregated information
	AUD	A$0.55		300,000	A$165,000
(e)	Date of transaction		10 January 2024
(f)	Place of transaction		Outside a trading venue

1	Details of the person discharging managerial responsibilities/person closely associated
(a)	Name		Yifat Steuer
2	Reason for the notification
(a)	Position		Chief Operating Officer and Deputy CEO
(b)	Initial notification/amendment		Initial
(c)	If amendment: reason		n/a
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
	Full name of entity		MGC Pharmaceuticals Limited
	Legal Entity Identifier Code		213800HRE3FQJ6RK4H10
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
(a)	Description of the financial instrument, type of instrument		Fully Paid Ordinary Shares
(b)	Identification Code (ISIN)		AU000000MXC6
(c)	Nature of transaction		Shares issued as part of their working contracts and as consideration for services rendered in lieu of cash payments
(d)	Currency	Price		Volume	Total
	AUD	A$0.55		1,100,000	A$605,000
	Aggregated information
	AUD	A$0.55		1,100,000	A$605,000
(e)	Date of transaction		10 January 2024
(f)	Place of transaction		Outside a trading venue

1	Details of the person discharging managerial responsibilities/person closely associated
(a)	Name		Rowan Harland
2	Reason for the notification
(a)	Position		Company Secretary
(b)	Initial notification/amendment		Initial
(c)	If amendment: reason		n/a
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
	Full name of entity		MGC Pharmaceuticals Limited
	Legal Entity Identifier Code		213800HRE3FQJ6RK4H10
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
(a)	Description of the financial instrument, type of instrument		Fully Paid Ordinary Shares
(b)	Identification Code (ISIN)		AU000000MXC6
(c)	Nature of transaction		Shares issued as part of their working contracts and as consideration for services rendered in lieu of cash payments
(d)	Currency	Price		Volume	Total
	AUD	A$0.55		7,000	A$3,850
	Aggregated information
	AUD	A$0.55		7,000	A$3,850
(e)	Date of transaction		10 January 2024
(f)	Place of transaction		Outside a trading venue

1	Details of the person discharging managerial responsibilities/person closely associated
(a)	Name		Ana Arhar Oblak
2	Reason for the notification
(a)	Position		Group Financial Controller
(b)	Initial notification/amendment		Initial
(c)	If amendment: reason		n/a
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
	Full name of entity		MGC Pharmaceuticals Limited
	Legal Entity Identifier Code		213800HRE3FQJ6RK4H10
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
(a)	Description of the financial instrument, type of instrument		Fully Paid Ordinary Shares
(b)	Identification Code (ISIN)		AU000000MXC6
(c)	Nature of transaction		Shares issued as part of their working contracts and as consideration for services rendered in lieu of cash payments
(d)	Currency	Price		Volume	Total
	AUD	A$0.55		10,000	A$5,500
	Aggregated information
	AUD	A$0.55		10,000	A$5,500
(e)	Date of transaction		10 January 2024
(f)	Place of transaction		Outside a trading venue

-Ends-

Authorised for release by the Managing Director, for further information please contact:

MGC Pharmaceuticals Ltd              Roby Zomer CEO & Managing Director [phone] [e-mail]	MGC Pharmaceuticals Ltd Rowan Harland Company Secretary [phone] [e-mail]
UK IR/PR Advisers  IFC Advisory Graham Herring / Tim Metcalfe / Zach Cohen [phone] [e-mail]	UK Brokers Oberon Capital Aimee McCusker / Adam Pollock [phone] [e-mail] [e-mail]

 

END